Steep drop in cancer-causing infections in England due to HPV vaccine
The introduction of HPV vaccines has led to a sharp reduction in the number of young women with the cancer-causing infection in England, new data from Public Health England finds. (Source: CNN.com - Health)
Source: CNN.com - Health - June 18, 2018 Category: Consumer Health News Source Type: news

Living With Cancer: Ovarian cancer vaccine
Ovarian cancer vaccine: Can it prevent recurrence? Ovarian cancer vaccines are a type of immunotherapy, which is treatment that harnesses the body's germ-fighting immune system to attack cancer cells. Researchers hope to use ovarian cancer vaccines to train the immune system cells to detect and attack any cancer cells that reappear after initial treatment has [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 15, 2018 Category: Databases & Libraries Source Type: news

Parents see cancer prevention potential as best reason for HPV vaccination
(American Association for Cancer Research) Parents of adolescents believed that the potential to prevent certain types of cancer is the best reason for their children to receive the human papillomavirus (HPV) vaccine, whereas other reasons health care providers often give were far less persuasive. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2018 Category: International Medicine & Public Health Source Type: news

Case Comprehensive Cancer Center endorses elimination of HPV-related cancers
(Case Western Reserve University) Case Comprehensive Cancer Center has partnered with 69 other National Cancer Institute (NCI)-designated cancer centers to issue a statement urging increased HPV vaccination and screening to eliminate HPV-related cancers, starting with cervical cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2018 Category: Cancer & Oncology Source Type: news

Parents ranked cancer prevention as number one provider reason for HPV vaccination
(UNC Lineberger Comprehensive Cancer Center) Parents ranked cancer prevention as the most compelling reason health care providers can give for recommending the human papillomavirus (HPV) vaccine, according to a survey led by University of North Carolina Lineberger Comprehensive Cancer Center researchers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2018 Category: Cancer & Oncology Source Type: news

A Better Flu Shot May Be On the Horizon. Here ’s Why
Each year, influenza viruses bring aches, pains, fever and overall misery to millions of people. The flu also leads to hundreds of thousands of hospitalizations and thousands of deaths. In a new paper published in Genome Medicine, researchers say a blood test may be able to identify which people are more likely to fight off the flu and which may have a harder time. And information from that same test could lead to new treatments — including more effective vaccines — that might make more people more flu-resistant. For four years, Purvesh Khatri, an associate professor of medicine and biomedical data science at S...
Source: TIME: Health - June 14, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthytime public health Source Type: news

HPV infection rates remain high and many adolescents still aren ’t vaccinated, study says 
Just 38 percent of people who get their first HPV shot complete the vaccination series, leaving them vulnerable to the cancer-causing virus, a University of North Carolina study found. (Source: the Mail online | Health)
Source: the Mail online | Health - June 14, 2018 Category: Consumer Health News Source Type: news

A new kind of vaccine based on spider silk
(Universit é de Gen è ve) In order to strengthen the efficacy of vaccines on the immune system -- and in particular on T lymphocytes, specialized in the detection of cancer cells -- researchers from the universities of Geneva, Freiburg, Munich, and Bayreuth, in collaboration with the German company AMSilk, have developed spider silk microcapsules capable of delivering the vaccine directly to the heart of immune cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 12, 2018 Category: International Medicine & Public Health Source Type: news

Nurse guidance published on cervical cancer and HPV
Young women ‘too embarrassed’ to get screened Related items fromOnMedica Only a third of women with regular bloating would see their GP Parents unsure of HPV vaccine for daughters Third of emergency cancer presenters never saw GP Some doctors misunderstand smear test says GP Young women shun smear tests out of embarrassment (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 12, 2018 Category: UK Health Source Type: news

No OS Benefit From PROSTVAC-V/F in mCRPC
OS with the PSA-targeted, poxvirus-based cancer vaccine was no better than placebo, and increased survival was attributed to better standard of care. (Source: CancerNetwork)
Source: CancerNetwork - June 10, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news

UAB joins other cancer centers for HPV elimination venture
The UAB Comprehensive has partnered with 69 other cancer centers to push forward an initiative for increased HPV vaccination and screening to eliminate HPV-related cancers, starting with cervical cancer.   The institutions, which are National Cancer Institute-designated cancer centers, have recognized that insufficient vaccination is a public health threat and will call upon the nation’s health care providers, parents and adolescents to take advantage of the vaccine and start an initiative to… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 8, 2018 Category: Pharmaceuticals Authors: Tyler Patchen Source Type: news

The criminalization of science whistleblowers: A mind-blowing interview with Judy Mikovits, PhD
(Natural News) In one of the most shocking science videos you’ll see this year, molecular biologist Judy A. Mikovits, PhD, reveals the disturbing true story of how she was thrown in prison for blowing the whistle on deadly viral contamination of human vaccines. With a well established history of working for the National Cancer Institute... (Source: NaturalNews.com)
Source: NaturalNews.com - June 8, 2018 Category: Consumer Health News Source Type: news

Moffitt Partners with top cancer centers to endorse goal of eliminating HPV-related cancers
(H. Lee Moffitt Cancer Center& Research Institute) Moffitt Cancer Center has partnered with 69 other National Cancer Institute (NCI)-designated cancer centers, as well as the American Cancer Society, American Association for Cancer Research, American Society for Clinical Oncology, Association of American Cancer Institutes and America Society of Preventive Oncology, to issue a statement urging for increased HPV vaccination and screening to eliminate HPV-related cancers, starting with cervical cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 8, 2018 Category: International Medicine & Public Health Source Type: news

NCI Cancer Centers Endorse Goal of Eliminating HPV Cancers
THURSDAY, June 7, 2018 -- National Cancer Institute (NCI)-designated cancer centers are endorsing the goal of eliminating cancers caused by the human papillomavirus (HPV) through HPV vaccination and evidence-based cancer screening, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 7, 2018 Category: Pharmaceuticals Source Type: news

MD Anderson and nation's top cancer centers endorse goal of eliminating HPV-related cancers
(University of Texas M. D. Anderson Cancer Center) Recognizing that vaccination rates for the human papillomavirus (HPV) remain low across the U.S., particularly in Texas, The University of Texas MD Anderson Cancer Center again has joined with the 69 other National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement to call for increased HPV vaccination and evidence-based screening, with the goal of eliminating cancers caused by the virus. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 7, 2018 Category: Cancer & Oncology Source Type: news

UH Cancer Center partners with nation's top cancer centers to endorse goal
(University of Hawaii Cancer Center) University of Hawai'i Cancer Center has partnered with 69 other National Cancer Institute (NCI)-designated cancer centers to issue a statement urging for increased HPV vaccination and screening to eliminate HPV-related cancers, starting with cervical cancer. These institutions collectively recognize insufficient vaccination as a public health threat and call upon the nations' physicians, parents and young adults to take advantage of this rare opportunity to eliminate several different types of cancer in men and women.   (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 7, 2018 Category: Cancer & Oncology Source Type: news

UNC Lineberger among national leaders endorsing goal of eliminating HPV-related cancers
(UNC Lineberger Comprehensive Cancer Center) The directors of the 70 National Cancer Institute-designated cancer centers, including UNC Lineberger Comprehensive Cancer Center, say a national effort is needed to improve the rate of HPV vaccination and screening in the United States. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 7, 2018 Category: International Medicine & Public Health Source Type: news

St. Jude partners with NCI cancer centers with goal of eliminating HPV-related cancers
(St. Jude Children's Research Hospital) Joint statement empowers parents, young adults and physicians to act to increase vaccination rates and screenings to eliminate HPV-related cancers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 7, 2018 Category: International Medicine & Public Health Source Type: news

Mayo Clinic joins call for increased screening for HPV-related cancers
(Mayo Clinic) Mayo Clinic Cancer Center joined 69 other National Cancer Institute-designated cancer centers in calling for increased HPV vaccination and screening to eliminate HPV-related cancers. Participating centers issued a joint statement. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 7, 2018 Category: International Medicine & Public Health Source Type: news

Malaria: Cooperating antibodies enhance immune response
In this study, the researchers discovered a previously unnoticed characteristic of antibodies against the malaria parasite: They can cooperate with each other, thus binding even stronger to the pathogens and improving the immune response. The results, now published in Science, are expected to help develop a more effective vaccine against the disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 7, 2018 Category: Infectious Diseases Source Type: news

Mayo Clinic joins call for increased screening for HPV-related cancers
ROCHESTER, Minn. ? Mayo Clinic Cancer Center joined 69 other National Cancer Institute-designated cancer centers in calling for increased HPV vaccination and screening to eliminate HPV-related cancers. Participating centers issued a joint statement. According to the statement, nearly 80 million Americans ? 1 out of every 4 people ? are infected with HPV, and more [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 7, 2018 Category: Databases & Libraries Source Type: news

Medical News Today: Vaginal bacteria may have a role in cervical cancer
A new study reveals that microbe composition and other conditions in the vagina are linked to the development of cervical cancer in all its stages. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 6, 2018 Category: Consumer Health News Tags: Cervical Cancer / HPV Vaccine Source Type: news

A Biotech Executive Faces End-Stage Cancer As A Patient
Michael Becker used to be a biotech CEO. Now he wants people know about HPV, the vaccine-preventable virus that caused the cancer that spread from his throat into his lungs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 6, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Source Type: news

Personalized vaccine may increase long-term survival in people with deadliest form of brain cancer
An international study led by UCLA researchers has found that a personalized vaccine may help people with glioblastoma, the deadliest form of brain cancer, live longer. The vaccine, known as DCVax-L, uses a person ’s own white blood cells to help activate the immune system to fight cancer.Nearly 30 percent of people in the ongoing trial have survived for at least three years after they enrolled in the study. Currently, the average life expectancy for people diagnosed with glioblastoma is 15 to 17 months, and less than 5 percent of people who receive standard treatment survive more than five years after they are diagn...
Source: UCLA Newsroom: Health Sciences - June 5, 2018 Category: Universities & Medical Training Source Type: news

Personalized cancer vaccine may increase long-term survival in patients with deadly brain cancer
An international Phase III study led by researchers at UCLA and at Northwest Biotherapeutics, Inc. has found that a personalized glioblastoma vaccine may increase long-term survival in some patients. Nearly 30 percent of patients in the current trial have now survived at least three years post-enrollment, with patients continuing to be followed over time. (Source: World Pharma News)
Source: World Pharma News - June 4, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Personalized cancer vaccine may increase long-term survival in patients with deadly brain cancer
(University of California - Los Angeles Health Sciences) An international Phase III study led by researchers at UCLA has found that a personalized GBM vaccine may increase long-term survival in some patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2018 Category: Cancer & Oncology Source Type: news

Wayne State professor receives NSF CAREER award for vaccine adjuvant research
(Wayne State University - Office of the Vice President for Research) Haipeng Liu, Ph.D., assistant professor of chemical engineering at Wayne State University, received a Faculty Early Career Development (CAREER) award from the National Science Foundation to fund his research on vaccine adjuvants that can improve the treatment and care of cancer patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2018 Category: Cancer & Oncology Source Type: news

A great majority of Mozambican adolescent girls are willing to be vaccinated against HPV
(Barcelona Institute for Global Health (ISGlobal)) A study in Mozambique reveals that a majority of adolescent girls interviewed would be willing to get vaccinated against Human Papilloma Virus (HPV) if the vaccine was available in the country. These results are encouraging with regard to vaccine introduction and reducing mortality associated with cervical cancer in Mozambique. The investigation was led by the Manhi ç a Health Research Center (CISM) and ISGlobal, an institution supported by " la Caixa " Foundation (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2018 Category: Cancer & Oncology Source Type: news

Anti-HPV jab will be given to teenage boys if they identify as girls
The NHS will give a lifesaving cancer vaccine to teenage boys in the UK – but only if they ‘identify’ as girls. Taking the Gardasil jab will help them fit in with 'their peers', it is claimed. (Source: the Mail online | Health)
Source: the Mail online | Health - June 3, 2018 Category: Consumer Health News Source Type: news

Cleveland Clinic Cancer Center experts present data at 2018 ASCO Annual Meeting
(Cleveland Clinic) At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, researchers from Cleveland Clinic Cancer Center will present data from several new studies, including a prospective clinical trial examining non-small cell lung cancer cells' response to immunotherapy; research on germline testing for melanoma; and interim results from a study testing a vaccine for glioblastoma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 1, 2018 Category: International Medicine & Public Health Source Type: news

Uganda:Women Shun HPV Vaccine
[Monitor] Kampala -Women and girls in Uganda have continued to shun the Human Papilloma Vaccine (HPV) meant to protect them against cervical cancer, a new study has shown. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 31, 2018 Category: African Health Source Type: news

New report and resources put cancer in context, showing more than 1,100 medicines and vaccines in development
In the not too distant past, chemotherapy and radiation were once the only treatments for what remains the second leading cause of death in the United States – cancer. Although the death rates of cancer have declined in the past 20 years and survival rates have increased by five times since the 1970s, there is still more work to be done. The biopharmaceutical industry is leading by translating science into a completely new era of medicine for how we treat the diseases which make up cancer. (Source: The Catalyst)
Source: The Catalyst - May 30, 2018 Category: Pharmaceuticals Tags: Medicines in Development Research and Development cancer New Era of Medicine Source Type: news

Doctors Can Increase Vaccination Rates In Kids Using New Approach, Study Finds
Persistence and a unified, targeted approach can pay off for doctors when parents are reluctant to vaccinate their children against HPV, the human papilloma virus, a cause of anogenital, mouth, throat and cervical cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 30, 2018 Category: Pharmaceuticals Authors: Robert Glatter, MD, Contributor Source Type: news

Brain cancer vaccine could extend lives of patients by years
Trial on people with form of disease that killed Tessa Jowell ‘remarkably promising’A vaccine could add years to the lives of people with the aggressive form of brain cancer that killed theformer Labour cabinet minister Tessa Jowell, trials suggest.The treatment for people with glioblastoma works by using the immune cells of a patient to target their tumour. Early findings from an 11-year study involving more than 300 people worldwide shows that those given the vaccine were living longer than expected, according to a paper published in the Journal of Translational Medicine.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - May 29, 2018 Category: Science Authors: Press Association Tags: Cancer Cancer research Health Medical research Science Society UK news US news World news Pharmaceuticals industry Business Source Type: news

New vaccine may keep patients alive 7 YEARS longer with the same cancer that killed Tessa Jowell
Scientists tested the DCVax-L injection, a form of immunotherapy, on more than 300 patients from the UK, US, Canada and Germany diagnosed with a glioblastoma. (Source: the Mail online | Health)
Source: the Mail online | Health - May 29, 2018 Category: Consumer Health News Source Type: news

Vaccine for cancer that killed Tessa Jowell 'remarkably promising'
A treatment for the cancer that killed Tessa Jowell could help to extend lives, a trial suggests. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 29, 2018 Category: Consumer Health News Source Type: news

No Link Between HPV Vaccine, Autoimmune Diseases: Study
(Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - May 29, 2018 Category: Cancer & Oncology Source Type: news

Tanzania:Over 5000 Girls Vaccinated for Cervical Cancer
[Daily News] MORE than 5000 girls in Dar es Salaam region have been vaccinated against cervical cancer since the vaccination campaign rolled out last April. The number is part of the targeted 24,097 girls to be reached in the fight against Human Papiloma Virus (HPV) which causes the disease. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 28, 2018 Category: African Health Source Type: news

DNA-based vaccine treatment for colorectal cancer to undergo first human study
(Digestive Disease Week) Combining a DNA vaccine, which boosts the body's immune response against tumors, with an antibody that blocks the body's natural defense against the potency of the DNA vaccine, may lead to the development of an effective treatment for late stage colorectal cancer, when a cure is not often possible. Preliminary research leading up to this trial will be presented at Digestive Disease Week ® 2018. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 22, 2018 Category: Cancer & Oncology Source Type: news

Medical News Today: Could Viagra and a flu shot kill cancer?
A Viagra, Cialis, and inactivated flu vaccine combination reduced cancer spread in a mouse model of post-surgery metastasis by helping the immune system. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 21, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

A mix of Viagra and the flu vaccine could treat cancer
The team at the University of Ottawa found that erectile dysfunction drugs block suppressor cells, allowing natural killer cells to do their cancer-fighting job. The flu vaccine further invigorates the killer cells. (Source: the Mail online | Health)
Source: the Mail online | Health - May 18, 2018 Category: Consumer Health News Source Type: news

Good Evidence That HPV Vaccines Protect Against Cervical Precancer
THURSDAY, May 17, 2018 -- Human papillomavirus (HPV) vaccines protect against cervical precancer in adolescent girls and young women, according to a review published online May 9 in the Cochrane Library. Marc Arbyn, M.D., from the Belgian Cancer... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2018 Category: Pharmaceuticals Source Type: news

ONCOS-102 Mesothelioma Trial Moves Forward
Oncologists in Spain are recruiting patients for the randomized phase of the pleural mesothelioma clinical trial involving ONCOS-102, the promising immunotherapy vaccine. Optimism surrounding the trial stems from encouraging results obtained recently in the six-patient safety cohort used as a precautionary lead-in. The trial involves the vaccine in combination with standard-of-care chemotherapy for patients with inoperable disease. ONCOS-102 is a scientifically engineered adenovirus that is designed to activate a patient’s immune system to selectively target cancer cells. It is being developed by Targovax, a Scandina...
Source: Asbestos and Mesothelioma News - May 17, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Sex, viruses and cancer
(The Ottawa Hospital) A new study suggests that a common treatment for erectile dysfunction combined with the flu vaccine may be able to help the immune system mop up cancer cells left behind after surgery. The study, published in OncoImmunology, shows that this unconventional strategy can reduce the spread of cancer by more than 90 percent in a mouse model. It is now being evaluated in a world-first clinical trial. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 17, 2018 Category: International Medicine & Public Health Source Type: news

Multi-epitope T-cell Vaccine Shows Promise in Ovarian, Breast Cancer
TPIV200 stimulates T cells to attack ovarian and triple negative breast tumor cells that over-express the folate receptor alpha protein. (Source: CancerNetwork)
Source: CancerNetwork - May 16, 2018 Category: Cancer & Oncology Authors: By John Schieszer Tags: Breast Cancer Immuno Oncology News Ovarian Cancer Source Type: news

Zimbabwe:Govt Rolls Out Anti-Cancer Vaccine in Schools
[The Herald] Government yesterday began the national roll-out of anti-cancer vaccine to girls between the ages of 10 and 14 years with a sizable number of girls agreeing to receiving the treatment in Harare. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 15, 2018 Category: African Health Source Type: news

Potential Role for Vaccines, Checkpoint Inhibitors in Chemoprevention of Lynch Syndrome
Researchers from MD Anderson say their study results " open the field of immunoprevention in LS to checkpoint inhibitors as an immune interception strategy. " (Source: CancerNetwork)
Source: CancerNetwork - May 11, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Colorectal Cancer Gastrointestinal Cancer News Source Type: news

Immunizing Cancer Patients: Which Patients? Which Vaccines? When to Give?
This article provides guidance to oncology clinicians on vaccine recommendations and safety of use in their patients. (Source: CancerNetwork)
Source: CancerNetwork - May 11, 2018 Category: Cancer & Oncology Authors: A Source Type: news

FDA Lays the Smackdown on Illegal Stem Cell Clinics
FDA is cracking down on stem cell clinics that market unapproved products and don't meet good manufacturing practice requirements. On behalf of the agency, the Department of Justice filed two complaints in federal court this week seeking permanent injunctions against a Florida-based clinic and a California-based clinic.  “Cell-based regenerative medicine holds significant medical opportunity, but we’ve also seen some bad actors leverage the scientific promise of this field to peddle unapproved treatments that put patients’ health at risk. In some instances, patients have suffered serious and per...
Source: MDDI - May 10, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news